ProPhase Labs, Inc. Nebula Genomics secures major international B2B deal – Additional significant B2B deals in final stages Ahead of schedule, Pharmaloz Manufacturing accelerates capacity ...

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated ProPhase Labs, Inc.

GARDEN CITY, NY, May 20, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today reported ...

ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript March 31, 2025 ProPhase Labs, Inc. misses on earnings expectations. Reported EPS is $-1.86 EPS, expectations were $-0.24.

ProPhase Labs (NASDAQ:PRPH) stock rose +12% Tuesday premarket as it named Stu Hollenshead as Chief Operating Officer, marking a pivotal step in the company’s expansion into consumer-centered ...

IN a preliminary study of chiasmata in female mice the meiotic prophase was observed in sixty-two females from a variety of strains, mostly outbred. It was found that in all strains the oogonial ...

GARDEN CITY, NY, March 31, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and ...